developed a new humanized CD93‐specific binding protein and evaluated the role of CD93 CAR‐T cells in leukaemia, and in vivo experiments showed that CD93 CAR‐T cells specifically cleared AML but not HSPC.92 The gene discussed is CD93; the disease is leukemia.